Clinical Trial Update: Japanese P III vs Voglibose and Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial in Japan comparing Boehringer Ingelheim's experimental compound to voglibose and placebo in type 2 diabetes; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• P III experimental Boehringer Ingelheim compound
• Voglibose (voglibose)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2011-08-02